Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA (samRNA) COVID-19 Vaccine at ESCMID Global 2024 [Yahoo! Finance]
Gritstone bio, Inc. (GRTS)
Last gritstone bio, inc. earnings: 11/12 09:01 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
-- Antigen-specific T cell responses increased in the majority of participants studied, including those living with HIV, after administration of any of the samRNA constructs -- -- Comprehensive data set demonstrates a consistent and strong immunogenicity profile across multiple patient populations in South Africa, including people living with HIV -- EMERYVILLE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world's most potent vaccines, today presented updated Phase 1 data from its CORAL-CEPI study, a Coalition for Epidemic Preparedness Innovations (CEPI)-funded study that is evaluating Gritstone's self-amplifying mRNA (samRNA) vaccine against COVID-19 in HIV-negative and people living with HIV (PLWH) participants. The presentation, at ESCMID Global 2024, reviewed the latest findings demonstrating the durability and potential broad utility of Gritstone's samRNA vaccine against COVID-19.
Show less
Read more
Impact Snapshot
Event Time:
GRTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GRTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRTS alerts
High impacting Gritstone bio, Inc. news events
Weekly update
A roundup of the hottest topics
GRTS
News
- Gritstone bio, Inc. (NASDAQ: GRTS) had its price target lowered by analysts at HC Wainwright from $7.00 to $4.00. They now have a "buy" rating on the stock.MarketBeat
- Gritstone bio, Inc. (NASDAQ:GRTS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]Yahoo! Finance
- Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesGlobeNewswire
- Here's How Cresco Labs (CRLBF) is Placed Before Q1 Earnings [Yahoo! Finance]Yahoo! Finance
GRTS
Earnings
- 5/9/24 - Miss
GRTS
Sec Filings
- 5/10/24 - Form DEFA14A
- 5/9/24 - Form 10-Q
- 5/9/24 - Form 8-K
- GRTS's page on the SEC website